To view this page ensure that Adobe Flash Player version 11.1.0 or greater is installed.
Foreword Daniel R Ouellette, MD, FCCP, has been a clinician, teacher, and researcher in pulmonary and critical care medicine for 25 years. Dr Ouellette is a Senior Staff Physician at Henry Ford Hospital in Detroit, Michigan, where he is the Medical Director of the Pulmonary Ward. He is also an Associate Professor of Medicine at the Wayne State University School of Medicine, the Medical Director of the Respiratory Therapy program at Oakland Community College, and is the Chair of the Guideline Oversight Committee for the American College of Chest Physicians (ACCP). Dr Ouellette has over 20 years of military service and was the Consultant to the US Army Surgeon General for Pulmonary Medicine during the last several years of his military career. He has been active in the leadership of the ACCP with previous positions including: Chair of the Clinical Pulmonary Network, Chair of the Council of Governors, and a member of the Board of Regents. Dr Ouellette had prominent leadership roles with the ACCP in the development of evidence-based clinical practice guidelines concerning antithrombotics, lung cancer, cough, immunosuppressive therapy in pulmonary disease, and pulmonary hypertension, and was a co-author of the American Association of Otolaryngology’s guideline on hoarseness. He has been co-Chair of the joint task force of the ACCP-American Thoracic Society (ATS) to develop the pulmonary recommendations for the Choosing Wisely Campaign. Dr Ouellette’s clinical areas of interest include general pulmonary and critical care medicine and evidence-based practice. W elcome to the first edition of US Respiratory & Pulmonary Diseases. This important new journal will bring review articles and editorials written by thought leaders in respiratory medicine to pulmonologists across the US and around the world. Case reports will allow readers to explore all areas of respiratory medicine and extend their knowledge and awareness of lung diseases. Our first edition begins with a report that concerns exciting new technology. Dr Pastis describes a novel steerable thoracostomy tube that allows the operator to direct the tube to a target area in the pleural space. The tube also permits passage of a bronchoscope, allowing the operator to visualize the pleural surfaces and other abnormalities. Editorials in this first edition address recent advances in the management of idiopathic pulmonary fibrosis and the respiratory care of obese patients. Readers will appreciate thoughtful reviews addressing endobronchial involvement in sarcoid and noninvasive measurements of airway inflammation in asthma and chronic obstructive pulmonary disease. Finally, pulmonologists will be intrigued by an unusual case report of a fungal empyema in a cystic fibrosis patient occurring late after transplantation. US Respiratory & Pulmonary Diseases would like to hear from any leading authorities who would like to discuss article submissions, and is also interested in industry-sponsored articles that are balanced and relevant. We are particularly interested in concise reviews on new treatments, drugs, and technologies, although we also welcome short case series and original research material. Our journal adheres to the publication guidelines recommended by the International Committee of Medical Journal Editors and the Good Publication Practice guidelines. All articles are subjected to a rigorous, double-blind peer review process. The “Instructions for Authors” information is available for download. US Respiratory & Pulmonary Diseases would like to thank all expert authors who contributed towards this edition. A special thanks goes to our Editorial Board for their support and guidance in this new venture. We hope that you enjoy this journal and find plenty of interest among these timely articles. ■ © TO U CH MED ICA L MEDIA 11